Luis Teixeira

5PUBLICATIONS
42CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 25, 2024
Efficacy of administration sequence: Sacituzumab Govitecan and Trastuzumab Deruxtecan in HER2-low metastatic breast cancer.

F Poumeaud, M Morisseau, L Cabel

|Nov 06, 2023
Overall Survival With Circulating Tumor Cell Count-Driven Choice of Therapy in Advanced Breast Cancer: A Randomized Trial.

François-Clément Bidard, Nicolas Kiavue, William Jacot

|Sep 07, 2022
Safety, Immunogenicity, and 1-Year Efficacy of Universal Cancer Peptide-Based Vaccine in Patients With Refractory Advanced Non-Small-Cell Lung Cancer: A Phase Ib/Phase IIa De-Escalation Study.

Olivier Adotévi, Dewi Vernerey, Pascale Jacoulet

|Feb 05, 2022
Downregulation of the FTO m6A RNA demethylase promotes EMT-mediated progression of epithelial tumors and sensitivity to Wnt inhibitors.

Jana Jeschke, Evelyne Collignon, Clémence Al Wardi

|Aug 29, 2020
Oncogenic TRIM37 Links Chemoresistance and Metastatic Fate in Triple-Negative Breast Cancer.

Piotr Przanowski, Song Lou, Rachisan Djiake Tihagam

Pageof 1

Frequent Collaborators

2 joint publications

Luc Cabel

2 joint publications

William Jacot

1 joint publications

F Poumeaud

1 joint publications

J-S Frenel